About: Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1993

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) bài báo khoa học (vi) наукова стаття, опублікована в травні 1993 (uk) im Mai 1993 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1993 (ast) scientific article published on 01 May 1993 (en) գիտական հոդված հրատարակված 1993 թվականի մայիսի 1-ին (hy)
publication date	wds:Q72217954-8F3ADEE7-71EC-4C6E-A63F-6892147D24D7
publication date	1993-05-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72217954-F9D82682-7DAF-43D1-96D3-E66E9EAC5C8C
language of work or name	English
author name string	wds:Q72217954-117125A7-9B00-4853-8B65-D67C46A6ABE8 wds:Q72217954-2005D165-09E6-4935-B5B0-FAE8CEBF74E9 wds:Q72217954-2CDC005F-456B-4205-ACFB-D8377B826797 wds:Q72217954-4F99B72B-031A-4F93-ABA7-7326263940D7 wds:Q72217954-65B8B056-E3BC-4638-B4BB-13C44FC4E708 wds:Q72217954-7AA3799B-FDAB-481B-8B3B-CA6337863B5E wds:Q72217954-A4BE772E-EB7F-4C70-8A0A-900C46BA5E6A wds:Q72217954-D0523E57-A29B-4B81-A811-551E99804D9B wds:Q72217954-EA3D4A4F-5993-4AB4-A97A-D7ADD322FE43 wds:Q72217954-F741A4D1-EF2E-4F30-B9F1-2B869E2BB652
author name string	G Weiss L Smith S Fields J Kuhn G Rodriguez J Eckardt D Shaffer R Irvin H Burris S Kalter
rdfs:label	Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (en) Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (nl)
skos:prefLabel	Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (en) Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (nl)
name	Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (en) Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (nl)
title	wds:Q72217954-17C1A7CA-A3CC-48D5-952D-F0504039D6A8
title	Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion (en)
page(s)	wds:Q72217954-314AF6E1-6260-4976-BFB6-E45CBFCE2E1B
page(s)	950-958
instance of	wds:Q72217954-80387DE2-576B-45A4-9472-65DDA84490FC
instance of	scholarly article
main subject	wds:Q72217954-179AB56C-4CB7-4FB5-B3F1-F9F800E711B9 wds:Q72217954-5D4F7027-195E-46A5-979B-CD7BAF93CBD3
main subject	phase I clinical trial wd:Q420436
PubMed ID	wds:Q72217954-57F2AF13-35AD-4478-891C-128734D7B766
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8098059
PubMed ID	8098059
published in	wds:Q72217954-4C51D5AA-FCC5-482B-AA5C-C1231C3D7B5F
published in	Journal of Clinical Oncology
issue	wds:Q72217954-471DD337-6FC3-4367-90EA-8CA8CC360D7A
volume	wds:Q72217954-D559D694-975A-43BB-B529-BF8300CD5B76
issue	5
volume	11
DOI	wds:Q72217954-7C054CD9-4E80-43C0-9282-E82529833D04
DOI	http://dx.doi.org/10.1200/JCO.1993.11.5.950
DOI	10.1200/JCO.1993.11.5.950
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72217954
is cites work of	Current status of Taxotere (docetaxel) as a new treatment in breast cancer Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group Pharmacological effects of formulation vehicles : implications for cancer chemotherapy Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor Phase I study on docetaxel and ifosfamide in patients with advanced solid tumours Docetaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of metastatic breast cancer Clinical pharmacokinetics of docetaxel. A multicentre phase II study of docetaxel 75 mg m-2 as first-line chemotherapy for patients with advanced breast cancer: report of the Clinical Screening Group of the EORTC. European Organization for Research and Treatment of Cancer Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293. Phase I evaluation of docetaxel and topotecan for patients with advanced solid tumors The taxoids. Comparative clinical pharmacology and therapeutic potential A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours Docetaxel: an update of its use in advanced breast cancer Docetaxel: a review of its use in non-small cell lung cancer Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro Reducing the time interval between cycles using standard doses of docetaxel and lenogastrim support: a feasibility study A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck Radiotherapy with concomitant weekly docetaxel for Stages III/IV oropharynx carcinoma. Results of the 98-02 GORTEC Phase II trial Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine Risks and benefits of taxanes in breast and ovarian cancer Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy A preclinical evaluation of pemetrexed and irinotecan combination as second-line chemotherapy in pancreatic cancer Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in Stage III non-small-cell lung cancer Bio-analysis of docetaxel and hydroxylated metabolites in human plasma by high-performance liquid chromatography and automated solid-phase extraction Advanced non-small cell lung carcinoma: the emerging role of docetaxel Characterization of endogenous G-CSF and the inverse correlation to chemotherapy-induced neutropenia in patients with breast cancer using population modeling Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography Biodistribution and radiation dosimetry of 11C-labelled docetaxel in cancer patients Taxanes in lung cancer: a review with focus on the European experience A phase I dose-escalation study of docetaxel with granulocyte colony-stimulating factor support in patients with solid tumours Cardiovascular toxicity with cancer chemotherapy Phase 1 dose escalation study of docetaxel with filgrastim support in patients with advanced solid tumors Taxanes: their impact on gynecologic malignancy Docetaxel and ketoconazole in advanced hormone-refractory prostate carcinoma: a phase I and pharmacokinetic study Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: Validation and stability

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software